Molecular and biologic markers of progression in monoclonal gammopathy of undetermined significance to multiple myeloma

DNA methylation analysis of tumor suppressor genes in monoclonal gammopathy of undetermined significance

(2009) Carmen Stanganelli et al.   ANNALS OF HEMATOLOGY

A monoclonal gammopathy precedes multiple myeloma in most patients

(2009) B. M. Weiss et al.   BLOOD

Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

(2009) O. Landgren et al.   BLOOD

Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden

(2009) O. Landgren et al.   BLOOD

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Dynamic Contrast-Enhanced Magnetic Resonance Imaging Identifies a Subgroup of Patients with Asymptomatic Monoclonal Plasma Cell Disease and Pathologic Microcirculation

(2009) J. Hillengass et al.   CLINICAL CANCER RESEARCH

Gene Expression Profiling of Bone Marrow Endothelial Cells in Patients with Multiple Myeloma

(2009) R. Ria et al.   CLINICAL CANCER RESEARCH

Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context

(2009) L. Chiecchio et al.   HAEMATOLOGICA

Gene Expression Profiles of Tumor Biology Provide a Novel Approach to Prognosis and May Guide the Selection of Therapeutic Targets in Multiple Myeloma

(2009) Ariel Anguiano et al.   JOURNAL OF CLINICAL ONCOLOGY

A comprehensive catalogue of somatic mutations from a human cancer genome

(2009) Erin D. Pleasance et al.   NATURE

Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome

(2009) Elaine R. Mardis et al.   NEW ENGLAND JOURNAL OF MEDICINE

AID-Dependent Activation of a MYC Transgene Induces Multiple Myeloma in a Conditional Mouse Model of Post-Germinal Center Malignancies

(2008) Marta Chesi et al.   CANCER CELL

Aberrant gene promoter methylation in plasma cell dyscrasias

(2008) Paloma Martin et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Clinical and biological significance of RAS mutations in multiple myeloma

(2008) W J Chng et al.   LEUKEMIA

DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome

(2008) Timothy J. Ley et al.   NATURE

MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis

(2008) F. Pichiorri et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

(2007) A. Dispenzieri et al.   BLOOD